Covered recipient · General Payments record
BRADLY W STARKS
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$2,689.38
- Reported across 179 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $451.65 | 28 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $174.43 | 14 |
| Novo Nordisk AS | $103.15 | 5 |
| Lilly USA, LLC | $41.65 | 2 |
| E.R. Squibb & Sons, L.L.C. | $38.89 | 2 |
| Abbott Laboratories | $24.88 | 1 |
| Inspire Medical Systems, Inc. | $19.61 | 1 |
| Phathom Pharmaceuticals, Inc. | $18.29 | 1 |
| Amgen Inc. | $16.24 | 1 |
| PFIZER INC. | $14.51 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $24.88 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125206773 | CMS |
| ABBVIE INC. | $10.74 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106154829 | CMS |
| ABBVIE INC. | $7.62 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106154831 | CMS |
| ABBVIE INC. | $5.62 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106154833 | CMS |
| ABBVIE INC. | $10.22 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106154835 | CMS |
| ABBVIE INC. | $9.98 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106154837 | CMS |
| ABBVIE INC. | $13.18 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106154839 | CMS |
| ABBVIE INC. | $17.12 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106154841 | CMS |
| ABBVIE INC. | $8.78 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106154843 | CMS |
| ABBVIE INC. | $11.44 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106154845 | CMS |
| ABBVIE INC. | $12.79 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106154847 | CMS |
| ABBVIE INC. | $32.67 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106154849 | CMS |
| ABBVIE INC. | $7.41 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106154851 | CMS |
| ABBVIE INC. | $19.24 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106154853 | CMS |
| ABBVIE INC. | $7.62 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106154855 | CMS |
| Amgen Inc. | $16.24 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117390604 | CMS |
| E.R. Squibb & Sons, L.L.C. | $16.65 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101419019 | CMS |
| E.R. Squibb & Sons, L.L.C. | $22.24 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101419055 | CMS |
| Inspire Medical Systems, Inc. | $19.61 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148114416 | CMS |
| Lilly USA, LLC | $24.48 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136072469 | CMS |
| Lilly USA, LLC | $17.17 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136072665 | CMS |
| Novo Nordisk Inc | $19.80 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097549734 | CMS |
| Novo Nordisk Inc | $22.00 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096732034 | CMS |
| Novo Nordisk Inc | $22.00 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097210823 | CMS |
| Novo Nordisk Inc | $19.80 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097760269 | CMS |
| Novo Nordisk Inc | $19.55 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096938555 | CMS |
| PFIZER INC. | $14.51 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130874627 | CMS |
| Phathom Pharmaceuticals, Inc. | $18.29 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151129555 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.